Amgen Inc. P/E Ratio 2007–2025
Amgen Inc. reported 22.67 of price-to-earnings ratio for fiscal 2025. That was 31.1% lower than fiscal 2024. Compared with fiscal 2020, the change was +44.1%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive.
| Fiscal year | P/E Ratio | Change (YoY) |
|---|---|---|
| FY 2025 | 22.67 | -31.1% |
| FY 2024 | 32.91 | +54.0% |
| FY 2023 | 21.37 | +10.0% |
| FY 2022 | 19.42 | +2.2% |
| FY 2021 | 19.00 | +20.8% |
| FY 2020 | 15.73 | +2.5% |
| FY 2019 | 15.34 | +25.0% |
| FY 2018 | 12.27 | -75.4% |
| FY 2017 | 49.94 | +365.4% |
| FY 2016 | 10.73 | -18.2% |
| FY 2015 | 13.12 | -23.1% |
| FY 2014 | 17.07 | +41.1% |
| FY 2013 | 12.10 | +12.1% |
| FY 2012 | 10.80 | +0.1% |
| FY 2011 | 10.78 | +40.1% |
| FY 2010 | 7.69 | -8.6% |
| FY 2009 | 8.42 | -18.1% |
| FY 2008 | 10.28 | -9.6% |
| FY 2007 | 11.38 | — |
Source: Amgen Inc. SEC filings — fiscal-year-end price ÷ diluted EPS. Computed deterministically; refreshed nightly (last updated August 2, 2026). Open AMGN 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Amgen Inc. reported 22.67 of price-to-earnings ratio for fiscal 2025. That was 31.1% lower than fiscal 2024. Compared with fiscal 2020, the change was +44.1%. This is a fiscal-year-end price divided by diluted EPS—not a live valuation—and is omitted when annual EPS is not positive. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Amgen Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAmgen Inc. — frequently asked questions
What is Amgen Inc.'s price-to-earnings ratio?
Amgen Inc. (AMGN) reported price-to-earnings ratio of 22.67 for fiscal year 2025, per its SEC filings.
How has Amgen Inc.'s price-to-earnings ratio changed over time?
Between fiscal 2007 and 2025, AMGN's price-to-earnings ratio grew at roughly 3.9% per year (compound annual rate), from 11.38 to 22.67.
Where does this data come from?
Figures are computed from Amgen Inc.'s official SEC filings (fiscal-year-end price ÷ diluted EPS), refreshed nightly. Not investment advice.
More AMGN financial history
Full AMGN fundamentals page → · Analyze price-to-earnings ratio with a free tool → · Research guide & leaders → · All 1,500+ companies →